Top Markets
Coin of the day
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Rangering i aksjer #33504
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Aksjekurs
$1.12
Sist synkronisert: 2026-08-14
Markedsverdi
$7.52M
Endring (1 dag)
4.51%
Endring (1 år)
-94.79%
Land
US
Handel NeoImmuneTech, Inc. (950220)

Kategori

Historikk for aksjesplitt for NeoImmuneTech, Inc. (950220)
Aksjen NeoImmuneTech, Inc. (symbol: 950220) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 17, 2026.
Én 950220-aksje kjøpt før Aug 17, 2026 tilsvarer i dag 0 950220-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE